| Literature DB >> 32544542 |
Kinga Gawel1, Melanie Langlois2, Teresa Martins3, Wietske van der Ent4, Ettore Tiraboschi5, Maxime Jacmin3, Alexander D Crawford6, Camila V Esguerra7.
Abstract
Zebrafish are now widely accepted as a valuable animal model for a number of different central nervous system (CNS) diseases. They are suitable both for elucidating the origin of these disorders and the sequence of events culminating in their onset, and for use as a high-throughput in vivo drug screening platform. The availability of powerful and effective techniques for genome manipulation allows the rapid modelling of different genetic epilepsies and of conditions with seizures as a core symptom. With this review, we seek to summarize the current knowledge about existing epilepsy/seizures models in zebrafish (both pharmacological and genetic) and compare them with equivalent rodent and human studies. New findings obtained from the zebrafish models are highlighted. We believe that this comprehensive review will highlight the value of zebrafish as a model for investigating different aspects of epilepsy and will help researchers to use these models to their full extent.Entities:
Keywords: EEG; Epilepsy; Gene; High-throughput screening; Pharmacological models; Zebrafish
Mesh:
Year: 2020 PMID: 32544542 DOI: 10.1016/j.neubiorev.2020.06.010
Source DB: PubMed Journal: Neurosci Biobehav Rev ISSN: 0149-7634 Impact factor: 8.989